Sealantis

Haifa, Israel Founded: 2007 • Age: 19 yrs Acquired By Advanced Medical Solutions
Tissue adhesives are developed for surgery and drug delivery uses.
Annual revenue - Latest available
Total funding $3.0M 1 rounds
Employees - Tracked headcount
Investors 2 Known backers
Products - Services tracked
Competitors 9 Brand Intelligence

About Sealantis

Sealantis is a company based in Haifa (Israel) founded in 2007 was acquired by Advanced Medical Solutions in February 2019. Sealantis has raised $3 million across 1 funding round from investors including Advanced Medical Solutions and Teuza. Sealantis operates in a competitive market with competitors including Imbed Biosciences, Cresilon, Kane Biotech, Alafair Biosciences and Lohmann & Rauscher, among others.

  • Headquarter Haifa, Israel
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
Operational Areas
Healthcare → Medical Devices & Diagnostics
Healthcare → Pharmaceuticals & Therapeutics
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $3 M (USD)

    in 1 rounds

  • Latest Funding Round
    $3 M (USD), Series A

    Feb 18, 2015

  • Investors
  • Employee Count
    Employee Count
  • Acquired by
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Sealantis

Sealantis has successfully raised a total of $3M through 1 strategic funding round. The most recent funding activity was a Series A round of $3 million completed in February 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Series A — $3.0M
  • First Round

    (18 Feb 2015)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Feb, 2015 Amount Series A - Sealantis Valuation

investors

Investors in Sealantis

Sealantis has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Advanced Medical Solutions and Teuza.

All
Venture Fund
Investor Description Founded Year Domain Location
Investments are made in stage-agnostic Israeli companies by Teuza.
Founded Year Domain Location
Wound care products and surgical dressings are developed.
Founded Year Domain Location

Investments & Acquisitions by Sealantis

Investments

Financial Statements - Sealantis

Sealantis Comparisons

+
Add Comparison
Available on Premium

Competitors of Sealantis

Sealantis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Imbed Biosciences, Cresilon, Kane Biotech, Alafair Biosciences and Lohmann & Rauscher, among others.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Nanotech-based wound care products are developed and provided.
domain founded_year HQ Location
Developer of hemostatic products for wound care
domain founded_year HQ Location
Therapeutic solutions for biofilm prevention and removal are developed.
domain founded_year HQ Location
Biomaterials and devices for internal wound healing are developed.
domain founded_year HQ Location
Dressing materials and medical devices
domain founded_year HQ Location
Wound-healing therapies for oral surgery and chronic wounds are developed.

Latest news on Sealantis

Frequently Asked Questions about Sealantis

Sealantis was founded in 2007 and raised its 1st funding round 8 years after it was founded.

Sealantis is headquartered in Haifa, Israel. It is registered at Haifa, Haifa District, Israel.

Sealantis is a funded company, having raised a total of $3M across 1 funding round to date. The company's 1st funding round was a Series A of $3M, raised on Feb 18, 2015.

Sealantis was founded in 2007 and is headquartered in Haifa, Israel. Operations center on biotechnology, where an alga-mimetic adhesive platform is developed to replicate algaes underwater adhesion processes. This technology supports applications in surgical procedures, wound management, and controlled drug delivery mechanisms. The focus remains on advancing medical adhesion solutions within the health tech sector.

Sealantis's top competitors include Imbed Biosciences, Cresilon and Kane Biotech.

Sealantis has 2 investors. Key investors include Advanced Medical Solutions, and Teuza.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available